SCAND2P and head and neck squamous cell carcinoma: Similarly, high expressions of SCAND2, SCAND1, and MZF1 genes were significantly correlated with enhanced prognosis of patients suffering from stage III head and neck squamous cell carcinoma (SCC) (Figure 9A–C), whereas high expression levels of HSP90AA1 and HSP90AB1 genes were significantly correlated with poorer prognosis of patients suffering from stage III head and neck SCC (Figure 9D,E).